DXCM Relative Valuation
DXCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DXCM is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for DXCM's competitors is 5.71, providing a benchmark for relative valuation. Dexcom Inc Corp (DXCM) exhibits a P/S ratio of 7.04, which is 23.22% above the industry average. Given its robust revenue growth of 12.49%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Dexcom Inc (DXCM) currently overvalued or undervalued?
What is Dexcom Inc (DXCM) fair value?
How does DXCM's valuation metrics compare to the industry average?
What is the current P/B ratio for Dexcom Inc (DXCM) as of May 19 2025?
What is the current FCF Yield for Dexcom Inc (DXCM) as of May 19 2025?
What is the current Forward P/E ratio for Dexcom Inc (DXCM) as of May 19 2025?